The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
The Epidemiology of Sepsis in the United States from 1979 through 2000
Open accessAbstract
BACKGROUND: Sepsis represents a substantial health care burden, and there is limited epidemiologic information about the demography of sepsis or about the temporal changes in its incidence and outcome. We investigated the epidemiology of sepsis in the United States, with specific examination of race and sex, causative organisms, the disposition of patients, and the incidence and outcome. METHODS: We analyzed the occurrence of sepsis from 1979 through 2000 using a nationally representative sample of all nonfederal acute care hospitals in the United States. Data on new cases were obtained from hospital discharge records coded according to the International Classification of Diseases, Ninth Revision, Clinical Modification. RESULTS: Review of discharge data on approximately 750 million hospitalizations in the United States over the 22-year period identified 10,319,418 cases of sepsis. Sepsis was more common among men than among women (mean annual relative risk, 1.28 [95 percent confidence interval, 1.24 to 1.32]) and among nonwhite persons than among white persons (mean annual relative risk, 1.90 [95 percent confidence interval, 1.81 to 2.00]). Between 1979 and 2000, there was an annualized increase in the incidence of sepsis of 8.7 percent, from about 164,000 cases (82.7 per 100,000 population) to nearly 660,000 cases (240.4 per 100,000 population). The rate of sepsis due to fungal organisms increased by 207 percent, with gram-positive bacteria becoming the predominant pathogens after 1987. The total in-hospital mortality rate fell from 27.8 percent during the period from 1979 through 1984 to 17.9 percent during the period from 1995 through 2000, yet the total number of deaths continued to increase. Mortality was highest among black men. Organ failure contributed cumulatively to mortality, with temporal improvements in survival among patients with fewer than three failing organs. The average length of the hospital stay decreased, and the rate of discharge to nonacute care medical facilities increased. CONCLUSIONS: The incidence of sepsis and the number of sepsis-related deaths are increasing, although the overall mortality rate among patients with sepsis is declining. There are also disparities among races and between men and women in the incidence of sepsis. Gram-positive bacteria and fungal organisms are increasingly common causes of sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This approach follows the methods validated by many studies on the epidemiology of sepsis26, 27, 28, 29 and was used by Rudd and colleagues.10”
From Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 (2024) · cites this paper as [28]
In the citing paper
“This trend continued with a greater than 200% increase from 1979 to 2000.23”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [23]
In the citing paper
“McNeil et al. (154) published an analysis of trends in infectious disease mortality in the United States and found a dramatic increase in multiple-cause mortality due to mycoses, from 1,557 deaths in 1980 to 6,534 deaths in 1997; the majority of these mycoses-related deaths were associated with Candida , Aspergillus , and Cryptococcus sp. infection.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“At the same time, they showed an almost exponential increase in the mortality rates associated with IA, with a 357% increase in mortality between 1980 and 1996.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“Previously, McNeil et al. (154) demonstrated that mortality rates associated with IC increased steadily from 1980 to a peak in 1989, followed by a gradual decline through 1996.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“These data are directly comparable to those of McNeil et al. (154) and extend the data reported in that study beyond 1996 to the year 2003.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“Again, the limitations of such data are well known, most notably the lack of validation of the mycotic infection and the failure to clinically diagnose IA and IC, resulting in an underestimation of mortality (154).”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“As stated by McNeil and colleagues (154), mortality associated with invasive mycoses is best represented by multiplecause-of-death data, which capture any mention of the mycotic disease on the death certificate.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
In the citing paper
“Although this approach provides a much more generalizable sample of U.S. hospitals than many other methods of surveillance, it is likely to underestimate both incidence and mortality because of miscoding of IC, use of codes not captured by the analysis, or failure to code the infection at all (79, 154).”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [154]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., BALK, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · CHEST Journal · doi:10.1378/chest.101.6.1644 · Cited by 13,317
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J., Laterre, P., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,124
Rising Incidence of Hepatocellular Carcinoma in the United States
El‐Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,865
The Natural History of the Systemic Inflammatory Response Syndrome (SIRS)
Rangel-Frausto, M. S., Pittet, D., Costigan, M., Hwang, T., Davis, C. S., & Wenzel, R. P. (1995) · JAMA · doi:10.1001/jama.273.2.117 · Cited by 2,090
High-Dose Antithrombin III in Severe Sepsis
Warren, B., Eid, A. A., Singer, P., Pillay, S., Carl, P., Novák, I., Chalupa, P., Atherstone, A., Pénzes, I., Kübler, A., et al. (2001) · JAMA · doi:10.1001/jama.286.15.1869 · Cited by 1,422
Parrillo, J. E., Parker, M. M., Natanson, C., Suffredini, A. F., Danner, R. L., Cunnion, R. E., & Ognibene, F. P. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-227 · Cited by 1,188
Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Beck‐Sagué, C. M., Jarvis, W. R., & System, N. N. I. S. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in Adults
Brun‐Buisson, C. (1995) · JAMA · doi:10.1001/jama.274.12.968 · Cited by 1,079
Treating Patients with Severe Sepsis
Wheeler, A. P., & Bernard, G. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400307 · Cited by 992
Research works printed but not linked: 2
- 1990, MMWR Morb Mortal Wkly Rep, 39, 31
- Eaton S, 2002, Am J Respir Crit Care Med, 165, A471
Cited by
Sorted by citations
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02724-0 · Cited by 16,316
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Rudd, K. E., Johnson, S. C., Agesa, K. M., Shackelford, K. A., Tsoi, D., Kievlan, D. R., Colombara, D. V., Ikuta, K. S., Kissoon, N., Finfer, S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32989-7 · Cited by 7,971
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,371
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun‐Buisson, C., Beale, R. J., et al. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,789
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
Severe Sepsis and Septic Shock
Angus, D. C., & van der Poll, T. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208623 · Cited by 4,119
Naghavi, M., Vollset, S. E., Ikuta, K. S., Swetschinski, L. R., Gray, A. P., Wool, E. E., Robles Aguilar, G., Mestrovic, T., Smith, G., Han, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01867-1 · Cited by 3,791
Incidence and Outcomes of Acute Lung Injury
Rubenfeld, G. D., Caldwell, E., Peabody, E., Weaver, J., Martin, D. P., Neff, M., Stern, E. J., & Hudson, L. D. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050333 · Cited by 3,684
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,639
Fleischmann, C., Scherag, A., Adhikari, N. K. J., Hartog, C. S., Tsaganos, T., Schlattmann, P., Angus, D. C., & Reinhart, K. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0781oc · Cited by 3,548
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002
Klevens, R. M., Edwards, J. R., Richards, C. L., Horan, T. C., Gaynes, R. P., Pollock, D. A., & Cardo, D. M. (2007) · Public Health Reports · doi:10.1177/003335490712200205 · Cited by 2,963
Sepsis in European intensive care units: Results of the SOAP study*
Vincent, J., Sakr, Y. L., Sprung, C. L., Ranieri, V. M., Reinhart, K., Gerlach, H., Moreno, R. P., Carlet, J. M., Gall, J. L., & Payen, D. M. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000194725.48928.3a · Cited by 2,823
Long-term cognitive impairment and functional disability among survivors of severe sepsis.
Iwashyna, T. J., Ely, E. W., Smith, D. M., & Langa, K. M. (2010) · JAMA · doi:10.1001/jama.2010.1553 · Cited by 2,582
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock
Shankar‐Hari, M., Phillips, G. S., Levy, M. L., Seymour, C. W., Liu, V. X., Deutschman, C. S., Angus, D. C., Rubenfeld, G. D., Singer, M., & for the Sepsis Definitions Task Force (2016) · JAMA · doi:10.1001/jama.2016.0289 · Cited by 2,499
Cecconi, M., Evans, L., Levy, M., & Rhodes, A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30696-2 · Cited by 2,254
Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014.
Rhee, C., Dantes, R., Epstein, L., Murphy, D. J., Seymour, C. W., Iwashyna, T. J., Kadri, S. S., Angus, D. C., Danner, R. L., Fiore, A. E., et al. (2017) · JAMA · doi:10.1001/jama.2017.13836 · Cited by 1,884
Self-citationMacrophage migration inhibitory factor: a regulator of innate immunity
Calandra, T., & Roger, T. (2003) · Nature reviews. Immunology · doi:10.1038/nri1200 · Cited by 1,782
Simon, L., Gauvin, F., Amre, D. K., Saint-Louis, P., & Lacroix, J. (2004) · Clinical Infectious Diseases · doi:10.1086/421997 · Cited by 1,802
Hotchkiss, R. S., Moldawer, L. L., Opal, S. M., Reinhart, K., Turnbull, I. R., & Vincent, J. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.45 · Cited by 1,795
Kaukonen, K.-M., Bailey, M., Suzuki, S., Pilcher, D., & Bellomo, R. (2014) · JAMA · doi:10.1001/jama.2014.2637 · Cited by 1,459
Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour
Ferrer, R., Martín‐Loeches, I., Phillips, G. S., Osborn, T. M., Townsend, S. R., Dellinger, R. P., Artigas, A., Schorr, C., & Levy, M. M. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000330 · Cited by 1,527
Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada
Kumar, A. (2009) · JAMA · doi:10.1001/jama.2009.1496 · Cited by 1,425
Benchmarking the Incidence and Mortality of Severe Sepsis in the United States*
Gaieski, D. F., Edwards, J. M., Kallan, M. J., & Carr, B. G. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827c09f8 · Cited by 1,356
Critical care and the global burden of critical illness in adults
Adhikari, N. K. J., Fowler, R., Bhagwanjee, S., & Rubenfeld, G. D. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60446-1 · Cited by 1,371
Drotrecogin Alfa (Activated) in Adults with Septic Shock
Ranieri, V. M., Thompson, B., Barie, P. S., Dhainaut, J.-F., Douglas, I. S., Finfer, S. R., Gårdlund, B., Marshall, J. C., Rhodes, A., Artigas, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202290 · Cited by 1,306
Sepsis: pathophysiology and clinical management
Gotts, J. E., & Matthay, M. A. (2016) · BMJ · doi:10.1136/bmj.i1585 · Cited by 1,308
Mayr, F., Yende, S. P., & Angus, D. C. (2013) · Virulence · doi:10.4161/viru.27372 · Cited by 1,298
Dombrovskiy, V. Y., Martin, A. A., Sunderram, J., & Paz, H. L. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000261890.41311.e9 · Cited by 1,253
Annane, D., Bellissant, É., & Cavaillon, J. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17667-8 · Cited by 1,262
Procalcitonin as a diagnostic marker for sepsis: A systematic review and meta-analysis.
Wacker, C., Prkno, A., Brunkhorst, F. M., & Schlattmann, P. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70323-7 · Cited by 1,198
Staphylococcus aureus Endocarditis: A Consequence of Medical Progress
Fowler, V. G., Miro, J. M., Hoen, B., Cabell, C. H., Abrutyn, E., Rubinstein, E., Corey, G. R., Spelman, D., Bradley, S. F., Barsic, B., et al. (2005) · JAMA · doi:10.1001/jama.293.24.3012 · Cited by 1,174
Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo
Yipp, B. G., Petri, B., Salina, D., Jenne, C. N., Scott, B. N. V., Zbytnuik, L. D., Pittman, K., Asaduzzaman, M., Wu, K., Meijndert, H. C., et al. (2012) · Nature Medicine · doi:10.1038/nm.2847 · Cited by 1,169
Gombart, A. F., Borregaard, N., & Koeffler, H. P. (2005) · The FASEB Journal · doi:10.1096/fj.04-3284com · Cited by 1,145
Measuring Diagnoses: ICD Code Accuracy
O’Malley, K. J., Cook, K. F., Price, M. D., Wildes, K. R., Hurdle, J. F., & Ashton, C. M. (2005) · Health Services Research · doi:10.1111/j.1475-6773.2005.00444.x · Cited by 1,156
Ronco, C., McCullough, P. A., Anker, S. D., Anand, I. S., Aspromonte, N., Bagshaw, S. M., Bellomo, R., Berl, T., Bobek, I., Cruz, D. N., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp507 · Cited by 1,137
Jones, A. E. (2010) · JAMA · doi:10.1001/jama.2010.158 · Cited by 1,085
Russell, J. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmra043632 · Cited by 1,054
The effect of age on the development and outcome of adult sepsis*
Martin, G. S., Mannino, D. M., & Moss, M. M. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000194535.82812.ba · Cited by 1,062
Self-citationAcute Kidney Injury Is Associated With Increased Long-Term Mortality After Cardiothoracic Surgery
Hobson, C., Yavas, S., Segal, M. S., Schold, J. D., Tribble, C. G., Layon, A. J., & Bihorac, A. (2009) · Circulation · doi:10.1161/circulationaha.108.800011 · Cited by 1,007
Sepsis: a roadmap for future research
Cohen, J., Vincent, J., Adhikari, N. K. J., Machado, F. R., Angus, D. C., Calandra, T., Jaton, K., Giulieri, S. G., Delaloye, J., Opal, S. M., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70112-x · Cited by 1,038
Fleischmann-Struzek, C., Mellhammar, L., Rose, N., Cassini, A., Rudd, K. E., Schlattmann, P., Allegranzi, B., & Reinhart, K. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06151-x · Cited by 982
Antifungal activity of silver nanoparticles against Candida spp.
Panáček, A., Kolář, M., Večeřová, R., Prucek, R., Soukupová, J., Kryštof, V., Hamal, P., Zbořil, R., & Kvı́tek, L. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.065 · Cited by 970
Levy, M. M., Dellinger, R. P., Townsend, S. R., Linde‐Zwirble, W. T., Marshall, J. C., Bion, J., Schorr, C., Artigas, A., Ramsay, G., Beale, R. J., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181cb0cdc · Cited by 965
Epidemiology of Invasive Mycoses in North America
Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901
Sepsis associated acute kidney injury
Poston, J. T., & Koyner, J. L. (2019) · BMJ · doi:10.1136/bmj.k4891 · Cited by 917
Keel, M., & Trentz, O. (2005) · Injury · doi:10.1016/j.injury.2004.12.037 · Cited by 885
Optical sensor arrays for chemical sensing: the optoelectronic nose
Askim, J. R., Mahmoudi, M., & Suslick, K. S. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60179j · Cited by 885
Validity of diagnoses, procedures, and laboratory data in Japanese administrative data
Yamana, H., Moriwaki, M., Horiguchi, H., Kodan, M., Fushimi, K., & Yasunaga, H. (2017) · Journal of Epidemiology · doi:10.1016/j.je.2016.09.009 · Cited by 883
Levy, M. M., Dellinger, R. P., Townsend, S. R., Linde-Zwirble, W. T., Marshall, J. C., Bion, J., Schorr, C., Artigas, A., Ramsay, G., Beale, R., et al. (2010) · Intensive Care Medicine · doi:10.1007/s00134-009-1738-3 · Cited by 868
Candida parapsilosis , an Emerging Fungal Pathogen
Trofa, D. P., Gácser, A., & Nosanchuk, J. D. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00013-08 · Cited by 886
Klein, E. Y., Smith, D. L., & Laxminarayan, R. (2007) · Emerging infectious diseases · doi:10.3201/eid1312.070629 · Cited by 880
Levi, M. M., & van der Poll, T. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.11.007 · Cited by 881
Tang, B. M. P., Eslick, G. D., Craig, J. C., & McLean, A. S. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70052-x · Cited by 854
An interpretable machine learning model for accurate prediction of sepsis in the ICU
Nemati, S., Holder, A., Razmi, F., Stanley, M. D., Clifford, G. D., & Buchman, T. G. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000002936 · Cited by 832
Zaoutis, T. E., Argon, J., Chu, J., Berlin, J. A., Walsh, T. J., & Feudtner, C. (2005) · Clinical Infectious Diseases · doi:10.1086/496922 · Cited by 784
Incidence and Mortality of Acute Renal Failure in Medicare Beneficiaries, 1992 to 2001
Xue, J. L., Daniels, F., Star, R. A., Kimmel, P. L., Eggers, P. W., Molitoris, B. A., Himmelfarb, J., & Collins, A. J. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005060668 · Cited by 765
NF-κB activation as a pathological mechanism of septic shock and inflammation
Liu, S. F., & Malik, A. B. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00477.2005 · Cited by 769
Guidelines on Urological Infections
Grabe, M. J., Bartoletti, R., Cai, T., Köves, B., Peter Tenke, A., Wagenlehner, F., & Wullt, B. (2009) · Cited by 759
Paoli, C. J., Reynolds, M. A., Sinha, M., Gitlin, M., & Crouser, E. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003342 · Cited by 664
Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets—An Updated View
Schulte, W., Bernhagen, J., & Bucala, R. (2013) · Mediators of Inflammation · doi:10.1155/2013/165974 · Cited by 782
Mortality after Hospitalization with Mild, Moderate, and Severe Hyponatremia
Waikar, S. S., Mount, D. B., & Curhan, G. C. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.01.027 · Cited by 730
Mei, S. H. J., Haitsma, J. J., dos Santos, C. C., Deng, Y., Lai, P. F. H., Slutsky, A. S., Liles, W. C., & Stewart, D. J. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0010oc · Cited by 722
Paul, M., Shani, V., Muchtar, E., Kariv, G., Robenshtok, E., & Leibovici, L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00627-10 · Cited by 741
Early acute kidney injury and sepsis: a multicentre evaluation
Bagshaw, S. M., George, C., & Bellomo, R. (2008) · Critical Care · doi:10.1186/cc6863 · Cited by 691
Global trends in the distribution of Candida species causing candidemia
Guinea, J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12539 · Cited by 680
Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes
Martin, G. S. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.50 · Cited by 680
Self-citationMeisel, C., Schefold, J. C., Pschowski, R., Baumann, T., Hetzger, K., Gregor, J. I., Weber‐Carstens, S., Hasper, D., Keh, D., Zuckermann, H., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0363oc · Cited by 657
Two Decades of Mortality Trends Among Patients With Severe Sepsis
Stevenson, E. K., Rubenstein, A. R., Radin, G. T., Wiener, R. S., & Walkey, A. J. (2013) · Critical Care Medicine · doi:10.1097/ccm.0000000000000026 · Cited by 667
Control of TH17 cells occurs in the small intestine
Esplugues, E., Huber, S., Gagliani, N., Hauser, A. E., Town, T., Wan, Y. Y., O’Connor, W., Rongvaux, A., van Rooijen, N., Haberman, A. M., et al. (2011) · Nature · doi:10.1038/nature10228 · Cited by 660
(2004) · Intensive Care Medicine · doi:10.1007/s00134-003-2121-4 · Cited by 638
Riedemann, N. C., Guo, R., & Ward, P. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19523 · Cited by 638
Neuromuscular dysfunction acquired in critical illness: a systematic review
Stevens, R. D., Dowdy, D. W., Michaels, R. K., Méndez-Téllez, P. A., Pronovost, P. J., & Needham, D. M. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0772-2 · Cited by 638
The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation
de Jonge, W. J., & Ulloa, L. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707264 · Cited by 634
The role of mitochondrial dysfunction in sepsis-induced multi-organ failure
Singer, M. (2013) · Virulence · doi:10.4161/viru.26907 · Cited by 638
Long-term mortality and quality of life in sepsis: A systematic review*
Winters, B. D., Eberlein, M. H., Leung, J. M., Needham, D. M., Pronovost, P. J., & Sevransky, J. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181d8cc1d · Cited by 617
Physical Complications in Acute Lung Injury Survivors: A Two-Year Longitudinal Prospective Study
Fan, E., Dowdy, D. W., Colantuoni, E., Mendez-Tellez, P. A., Sevransky, J. E., Shanholtz, C., Dennison Himmelfarb, C. R., Desai, S. V., Ciesla, N., Herridge, M. S., et al. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000040 · Cited by 615
Nationwide Trends of Severe Sepsis in the 21st Century (2000–2007)
Kumar, G., Kumar, N., Taneja, A., Kaleekal, T. S., Tarima, S. S., McGinley, E. L., Jimenez, E. J., Mohan, A., Khan, R. A., Whittle, J., et al. (2011) · CHEST Journal · doi:10.1378/chest.11-0352 · Cited by 635
Epidemiology of sepsis in Germany: results from a national prospective multicenter study
Engel, C., Brunkhorst, F. M., Bone, H.-G., Brunkhorst, R. R., Gerlach, H., Grond, S., Gründling, M., Huhle, G., Jaschinski, U., John, S., et al. (2007) · Intensive Care Medicine · doi:10.1007/s00134-006-0517-7 · Cited by 609
Merx, M. W., & Weber, C. (2007) · Circulation · doi:10.1161/circulationaha.106.678359 · Cited by 613
Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: A meta-analysis
Huang, Z., Fu, Z., Huang, W., & Kegang, H. (2019) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2019.10.023 · Cited by 616
Declining Mortality in Patients with Acute Renal Failure, 1988 to 2002
Waikar, S. S., Curhan, G. C., Wald, R., McCarthy, E. P., & Chertow, G. M. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005091017 · Cited by 587
Hou, N., Li, M., He, L., Xie, B., Wang, L., Zhang, R., Yu, Y., Sun, X., Pan, Z., & Wang, K. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02620-5 · Cited by 580
Animal models of sepsis and sepsis-induced kidney injury
Doi, K., Leelahavanichkul, A., Yuen, P. S. T., & Star, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39421 · Cited by 585
Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis.
Nursing, M. R. I. C. U., Fowler, A. A., Syed, A. A., Knowlson, S., Sculthorpe, R., Farthing, D., DeWilde, C., Farthing, C. A., Larus, T. L., Martin, E., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-32 · Cited by 573
Russell, N., Seale, A. C., O’Driscoll, M., O’Sullivan, C. P., Bianchi-Jassir, F., Gonzalez-Guarin, J., Lawn, J. E., Baker, C. J., Bartlett, L., Cutland, C., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix658 · Cited by 579
The inflammatory response in sepsis
Bosmann, M., & Ward, P. A. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.09.004 · Cited by 559
Annane, D., Vignon, P., Renault, A., Bollaert, P., Charpentier, C., Martin, C., Troché, G., Ricard, J.-D., Nitenberg, G., Papazian, L., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61344-0 · Cited by 557
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Host–pathogen interactions in sepsis
van der Poll, T., & Opal, S. M. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70265-7 · Cited by 568
The risk of acute renal failure in patients with chronic kidney disease
Hsu, C., Ordoñez, J. D., Chertow, G. M., Fan, D., McCulloch, C. E., & Go, A. S. (2008) · Kidney International · doi:10.1038/ki.2008.107 · Cited by 552
The Role of the Liver in Sepsis
Yan, J., Li, S., & Li, S. (2014) · International Reviews of Immunology · doi:10.3109/08830185.2014.889129 · Cited by 549
Changes in hospital mortality for United States intensive care unit admissions from 1988 to 2012
Zimmerman, J. E., Kramer, A. A., & Knaus, W. A. (2013) · Critical Care · doi:10.1186/cc12695 · Cited by 533
Epidemiology and Outcomes of Acute Renal Failure in Hospitalized Patients
Liangos, O., Wald, R., O’Bell, J., Price, L. L., Pereira, B. J. G., & Jaber, B. L. (2005) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00220605 · Cited by 530
Excess Circulating Angiopoietin-2 May Contribute to Pulmonary Vascular Leak in Sepsis in Humans
Parikh, S. M., Mammoto, T., Schultz, A., Yuan, H.-T., Christiani, D., Karumanchi, S. A., & Sukhatme, V. P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030046 · Cited by 527
Temporal Changes in Incidence of Dialysis-Requiring AKI
Hsu, R. K., McCulloch, C. E., Dudley, R. A., Lo, L. J., & Hsu, C. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012080800 · Cited by 529
INNATE IMMUNE RESPONSE IN TH1- AND TH2-DOMINANT MOUSE STRAINS
Watanabe, H. A., Numata, K., Ito, T., Takagi, K., & Matsukawa, A. (2004) · Shock · doi:10.1097/01.shk.0000142249.08135.e9 · Cited by 522
Metadata
- Authors
- Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M.
- Affiliations
- Emory University (US)
- Centers for Disease Control and Prevention (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-04-17
- Volume
- 348
- Issue
- 16
- Pages
- 1546-1554
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2145577370
- Cited by
- 5,841
- References
- 48
- Citations by year
- 2026: 67 · 2025: 128 · 2024: 149 · 2023: 168 · 2022: 167 · 2021: 253 · 2020: 231 · 2019: 211 · 2018: 226 · 2017: 329 · 2016: 292 · 2015: 341 · 2014: 381 · 2013: 436 · 2012: 365
- FWCI
- 123.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- UKnowledge (University of Kentucky) (submittedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (AA R01-11660, R01AA011660)
- National Heart, Lung, and Blood Institute (K23HL067739, HL K23-67739)
- National Center for Research Resources (L30 RR020488)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- PSIS, sepsis incidence, sepsis mortality, temporal trends, racial disparities, sex differences, Gram-positive bacteria, fungal infection, sepsis pathogens, organ failure, length of hospital stay, hospital discharge disposition, Black men, hospital discharge data, acute care hospitals, healthcare burden
- MeSH terms
- Female, Humans, Male, Middle Aged, Multiple Organ Failure, Sex Factors, United States, Incidence, Survival Rate, Hospital Mortality, Sepsis, Racial Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
